Now I have all the information I need to write the consolidated review. Let me carefully cross-check each point and produce the final output.

---

## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy (DR) grading that self-generates lesion-like region proposals during training and inference, eliminating reliance on costly external annotations (e.g., lesion segmentations, vessel maps). The framework consists of two novel modules: (1) GALP, which derives grade-conditioned evidence maps from stage-wise auxiliary classifiers and selects top-K high-evidence regions as lesion proposals; and (2) LGRF, which routes cross-view lesion proposals through a gated mixture-of-experts with top-K-weighted cross-view attention. Evaluated on two multi-view DR benchmarks (MFIDDR and DRTiD), the annotation-free variant achieves 83.9% accuracy on MFIDDR and 76.0% on DRTiD, outperforming all end-to-end baselines and competing closely with annotation-dependent methods.

## Strengths

- **Self-derived lesion proposals demonstrably improve grading without external annotations.** The GALP module transforms auxiliary classifier outputs into grade-conditioned evidence maps and selects top-K regions as proposals (Section 3.2, Eqs. 3-7). The ablation study (Table 4) shows removing GALP drops accuracy from 83.9% to 82.7%, confirming that these self-derived cues contribute directly to performance while entirely avoiding external labels.

- **Cross-view lesion-expert fusion (LGRF) provides substantial and complementary gains.** The LGRF module routes cross-view proposals through a gated mixture-of-experts with top-K-weighted attention (Section 3.3). Removing LGRF drops accuracy to 82.3% and removing the expert pool drops it to 82.6% (Table 4), demonstrating that both the routing mechanism and the attention module are critical.

- **The annotation-free variant is competitive with externally informed methods.** On MFIDDR (Table 1), the method's 83.9% accuracy without external annotations surpasses several methods that require lesion/vessel annotations (e.g., LFMVDR with lesion at 82.2%, CVSA with vessel at 82.6%). On DRTiD (Table 3), the end-to-end variant achieves 76.0%, best overall, including over CrossFIT (75.6%) which uses OD and macula coordinates.

- **Robustness to hyperparameter choices.** Figure 3 shows accuracy varies by only ~1.5% across wide ranges of token retention ratio (0.2-1.0), number of experts (M=2-8), and routed experts (K₂=1-6), indicating the method is not brittle.

- **Well-structured ablation study.** The paper cleanly isolates the contribution of each module (GALP, LGRF, experts) and provides hyperparameter sensitivity analysis, giving strong internal evidence for the proposed architecture.

## Weaknesses

### Fatal

None.

### Major

- **Backbone mismatch in MFIDDR comparisons weakens the SOTA claim.** The paper uses Swin-B as backbone, while several baselines in Table 1 use different architectures (MVCNN_R uses ResNet-50, MVCNN_V uses VGG-19, MVCINN uses a custom CNN-transformer hybrid). The paper acknowledges this for CVSA (same ImageNet pretraining) but not for the other baselines. While the ablation study (Table 4) provides internally valid evidence for the proposed modules, the cross-paper SOTA comparisons against methods with weaker backbones are not on a level playing field. The DRTiD comparison (Table 3) is less affected since the paper follows CrossFIT's protocol including EyePACS pretraining. The core claim that self-derived proposals help grading is independently supported by the ablation, but the claim of achieving SOTA specifically relies on comparisons that do not control for backbone capacity.

### Minor

- **No statistical significance reporting.** All results are from a single train/test split without error bars, confidence intervals, or multiple runs. While the datasets have official fixed splits (standard in this subfield), the 0.4% accuracy margin on DRTiD (76.0% vs. 75.6%) could fall within run-to-run variance and cannot be confidently interpreted as a genuine improvement without uncertainty quantification.

- **"Lesion proposal" terminology is not validated against lesion masks.** The MFIDDR dataset includes automatic lesion segmentation masks, yet the paper provides no quantitative overlap analysis between the generated proposals and these masks. The proposals are technically *grade-discriminative* regions — the paper argues these should correspond to lesions, which is reasonable but empirically unverified. The ablation shows the proposals help grading, but the interpretability claim that they correspond specifically to lesions remains unsupported.

- **Single-adjacent-view fusion design is not justified or ablated.** For a four-view setting (MFIDDR), LGRF fuses each view only with its cyclic adjacent view (Section 3.3). No justification is given for this restriction, and no experiment compares it against fusing with all other views, which could be a natural design choice. The paper would benefit from either justifying this choice or showing it doesn't hurt performance.

- **RETFound multi-view baseline lacks implementation details.** Table 1 lists "RETFound (multi-view version)" but the paper provides no description of how the foundation model was adapted for multi-view inputs, making this comparison difficult to assess.

### Trivial

- **Load-balancing loss notation (Eq. 11) is imprecise.** The term $\hat{u}_m$ ("fraction of tokens actually assigned to expert $m$") is described verbally but not mathematically defined in terms of the routing mechanism, making the equation harder to follow.

## Nice-to-Haves

- An experiment replacing CAM-based proposal selection with random token selection (keeping the same number of tokens and the rest of the pipeline identical) would isolate the benefit of grade-conditioned proposal generation specifically, beyond just token reduction.

- Qualitative visualizations of the grade-conditioned evidence maps overlaid on fundus images, alongside the available lesion segmentation masks, would strengthen both the interpretability narrative and the "lesion proposal" terminology.

- Reporting results over multiple independent runs or cross-validation folds would convert small numerical advantages into statistically meaningful statements.

## Removed Points

These points are flagged to be removed; treat them with caution:

- **Harsh Critic: "The narrative that end-to-end models rely on downsampling or tokenization that compresses spatial detail is somewhat misapplied to the proposed method."** *Removed.* The paper's framing is about how standard end-to-end pipelines uniformly compress all spatial regions, whereas the proposed method selectively retains high-evidence regions via GALP. This is a meaningful distinction; the harsh critic's objection is a framing nitpick that doesn't identify an actual error.

- **Harsh Critic: "The conclusion that the method 'achieves SOTA performance' is not adequately supported" as a fatal/structural claim.** *Demoted to Major and narrowed.* The core method contribution (self-derived proposals) is well-supported by the ablation. The SOTA comparison weakness is real but does not invalidate the paper — it weakens the cross-paper comparison claim, not the internal evidence for the method.

- **Strength Finder: All strengths verified as valid.** None removed — all are concrete and grounded in specific tables/figures from the paper.

## Novel Insights

The paper makes a practically valuable observation: grade-conditioned evidence maps derived from auxiliary classifiers can serve as effective surrogates for costly external lesion annotations in multi-view DR grading. This insight is distinct from both pure end-to-end methods (which lose fine-grained lesion detail through uniform compression) and externally informed methods (which require annotation pipelines). The ablation evidence confirms that the benefit comes specifically from grade-conditioned region selection (GALP) and cross-view expert routing (LGRF), rather than simply from the Swin-B backbone or additional parameters. This finding generalizes beyond DR: it suggests that self-derived attention to diagnostically salient regions can close the gap between annotation-free and annotation-dependent medical imaging pipelines.

## Suggestions

- **Replicate at least one strong baseline (e.g., MVCINN or ETMC) with the Swin-B backbone** to establish a fair comparison point, or explicitly qualify that some of the reported gains may partially reflect backbone differences rather than the proposed modules alone.

- **Add standard deviation or confidence intervals** from at least 3 independent runs for the main results, which would be straightforward to compute and would substantially strengthen the reliability of the reported margins.

- **Provide a brief justification or ablation for the single-adjacent-view fusion choice** — even a sentence explaining the design rationale (e.g., computational efficiency, empirical finding that more views don't help) would address a reviewer concern.

- **Add a simple overlap metric** (e.g., Dice or recall) between top-K GALP regions and the available MFIDDR lesion masks. This requires minimal additional computation and would directly validate the "lesion proposal" terminology.

## Score and Decision

### Calibration Anchors

| Anchor | Avg Score | Round | Comparison |
|--------|-----------|-------|------------|
| MVDream (FUgrjq2pbB) | 6.50 | R1 (mid) | Stronger: more impactful results, broader community value, better evaluation thoroughness |
| TEF (M3kBtqpys5) | 6.25 | R2 (narrow) | Slightly stronger: more extensive experiments (6 datasets), similar comparison-fairness issues but broader validation |
| M4oE (NJxCpMt0sf) | 5.75 | R2 (narrow) | Comparable: similar medical imaging MoE paper with novel framework, good ablations, similar weakness pattern (comparison fairness, statistical significance) |
| Eye Fairness (Lv9KZ5qCSG) | 5.50 | R1/R2 | Weaker: primarily a dataset contribution with limited technical novelty |

**Round 1 bracket:** Between 3.5 and 7.5 (broad). The paper is clearly above weak anchors (all unrelated to medical imaging, scores 1.67-3.40) and clearly below strong anchors (top-tier papers at 7.67-8.00).

**Round 2 narrowing:** Between ~5.5 and ~6.5. The paper is comparable to M4oE (5.75) in structure and weakness pattern but with cleaner motivation and more elegant technical design. It falls slightly below TEF (6.25) which has more extensive experimental validation (6 datasets vs. 2) and fewer confounding comparison variables.

**Final score: 6.0.** The paper presents a well-motivated, technically novel framework with strong internal ablation evidence. The core contribution — self-derived lesion proposals reduce annotation dependence — is convincingly demonstrated. However, backbone mismatches in cross-paper comparisons and the absence of statistical rigor prevent a higher score. The paper is a solid accept.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>